These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1718476)

  • 1. The effects of aprotinin on hemostatic function during cardiac surgery.
    Marx G; Pokar H; Reuter H; Doering V; Tilsner V
    J Cardiothorac Vasc Anesth; 1991 Oct; 5(5):467-74. PubMed ID: 1718476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
    Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
    Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass.
    Blauhut B; Gross C; Necek S; Doran JE; Späth P; Lundsgaard-Hansen P
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):958-67. PubMed ID: 1710008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pump-prime aprotinin dose in cardiac surgery: appraisal of its effects on the hemostatic system.
    Rossi M; Storti S; Martinelli L; Varano C; Marra R; Zamparelli R; Possati G; Schiavello R
    J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):835-9. PubMed ID: 9412880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the fibrinolytic, coagulation and plasma kallikrein-kinin systems during and after open heart surgery in children.
    Saatvedt K; Lindberg H; Michelsen S; Pedersen T; Geiran OR
    Scand J Clin Lab Invest; 1995 Jul; 55(4):359-67. PubMed ID: 7569739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
    Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
    Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
    Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
    Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a phase of hypercoagulability when aprotinin is used in cardiac surgery?
    Feindt P; Seyfert U; Volkmer I; Huwer H; Kalweit G; Gams E
    Eur J Cardiothorac Surg; 1994; 8(6):308-13; discussion 313-4. PubMed ID: 7522017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of high dose aprotinin in liver transplantation: the influence on fibrinolysis and blood loss.
    Grosse H; Lobbes W; Frambach M; von Broen O; Ringe B; Barthels M
    Thromb Res; 1991 Aug; 63(3):287-97. PubMed ID: 1720262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
    Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
    Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets.
    Orchard MA; Goodchild CS; Prentice CR; Davies JA; Benoit SE; Creighton-Kemsford LJ; Gaffney PJ; Michelson AD
    Br J Haematol; 1993 Nov; 85(3):533-41. PubMed ID: 7510990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.
    van Oeveren W; Harder MP; Roozendaal KJ; Eijsman L; Wildevuur CR
    J Thorac Cardiovasc Surg; 1990 May; 99(5):788-96; discussion 796-7. PubMed ID: 1691806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation.
    Havel M; Teufelsbauer H; Knöbl P; Dalmatiner R; Jaksch P; Zwölfer W; Müller M; Vukovich T
    J Thorac Cardiovasc Surg; 1991 Jun; 101(6):968-72. PubMed ID: 1710009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One month follow-up of haemostatic variables in patients undergoing aortocoronary bypass surgery. Effect of aprotinin.
    Mannucci L; Gerometta PS; Mussoni L; Antona C; Parolari A; Salvi L; Biglioli P; Tremoli E
    Thromb Haemost; 1995 Mar; 73(3):356-61. PubMed ID: 7545317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.
    Huang H; Ding W; Su Z; Zhang W
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):11-8. PubMed ID: 7686594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contact coagulation factors].
    Kojima T; Saito H
    Rinsho Byori; 1987 Apr; Spec No 70():79-87. PubMed ID: 3302400
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
    Mastroroberto P; Chello M; Zofrea S; Marchese AR
    Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.